awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26866958-BA4F6BA8-E3D5-4698-93CC-5B92D1FF8370
Q26866958-BA4F6BA8-E3D5-4698-93CC-5B92D1FF8370
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26866958-BA4F6BA8-E3D5-4698-93CC-5B92D1FF8370
Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies
P2860
Q26866958-BA4F6BA8-E3D5-4698-93CC-5B92D1FF8370
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26866958-BA4F6BA8-E3D5-4698-93CC-5B92D1FF8370
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30d3810b72284b205eefd078d4729cf37b1e28c6
P2860
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.